Saturday 17 October 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
340.66
0.75
−0.22%
Follow COR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
122.67% | 132.25% | 106.98% | 96.34% | |
Piotroski F-Score |
6 | 6 | 6 | 7 | |
| 2.16% | 2.20% | 3.33% | 3.33% | ||
ROIC |
32.52% | 20.29% | 12.64% | 15.65% | |
Return on Tangible Assets |
(51.08%) | (64.24%) | (1,370.54%) | (256.39%) | |
Average Days of Receivables |
28.65 | 29.11 | 27.64 | 27.91 | |
Free Cash Flow per Share |
16.55 | 18.79 | 8.23 | 21.26 | |
Free Cash Flow |
3,207.14 | 3,650.33 | 1,601.89 | 4,105.92 | |
Capital Expenditures |
(667.98) | (638.41) | (674.25) | (715.03) | |
| Other line items | |||||
Cash ROIC |
23.30% | 31.01% | 8.83% | 23.10% | |
Accounts Receivable Turnover |
13.09 | 12.90 | 13.52 | 13.31 | |
Accounts Payable Turnover |
5.87 | 5.92 | 6.20 | 6.04 | |
Inventory Turnover |
15.69 | 14.08 | 16.22 | 15.52 | |
Average Days of Payables |
64.46 | 65.21 | 59.90 | 62.48 | |
Days of Inventory on Hand |
24.14 | 28.01 | 23.10 | 24.02 | |
Tax Rate |
(0.31) | (0.30) | (0.27) | (0.27) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.02% | 2.09% | 2.19% | 2.30% | |
Share Based Compensation of Revenue |
0.05% | 0.04% | 0.04% | 0.04% | |
Interest Coverage |
9.02 | 7.98 | 7.49 | 7.05 | |
Operating CF/Net income |
2.49 | 2.64 | 0.89 | 1.84 | |
Depreciation/Fixed assets |
0.42 | 0.43 | 0.37 | 0.38 | |
Capex/Depreciation |
(0.63) | (0.61) | (0.64) | (0.67) | |
Revenue per Share |
1,657.89 | 1,677.37 | 1,689.48 | 1,722.89 | |
Operating CF per Share |
19.99 | 22.08 | 11.70 | 24.96 | |
Capex per Share |
(3.45) | (3.29) | (3.47) | (3.70) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates